Femi O Babatunde

ORCID, self-asserted

ORCID 0000-0001-6536-0259

Publications

Citations

h-index

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

Publications

7 works in the graph, newest first.

Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial
2026Nature MedicineJournalOpen access2 citations10.1038/s41591-026-04402-w
Insights into long-term antibody response in Lassa fever: A five-year follow-up study of Lassa fever survivors in Nigeria
2025Journal of Interventional Epidemiology and Public HealthJournalOpen access1 citations10.37432/jieph-confpro5-00079
Persistence and infectivity of Lassa virus in body fluids: Implications for survivor follow-up and public health
2025Journal of Interventional Epidemiology and Public HealthJournalOpen access0 citations10.37432/jieph-confpro5-00089
Evaluation of four lassa virus IgM immunoassays for early detection and seroprevalence studies in West Africa
2025Journal of Interventional Epidemiology and Public HealthJournalOpen access0 citations10.37432/jieph-confpro5-00174
Comparative Evaluation of Five Lassa Virus IgG Immunoassays for Seroprevalence Studies and Vaccine Trial Support in West Africa
2025Journal of Interventional Epidemiology and Public HealthJournalOpen access0 citations10.37432/jieph-confpro5-00183
Pharmacokinetics of Ribavirin in the Treatment of Lassa Fever: An Observational Clinical Study at the Irrua Specialist Teaching Hospital, Edo State, Nigeria
2022Clinical Infectious DiseasesJournalOpen access16 citations10.1093/cid/ciac578
Two Cases of Lassa Fever Successfully Treated with Ribavirin and Adjunct Dexamethasone for Concomitant Infections
2022Emerging infectious diseasesJournalOpen access8 citations10.3201/eid2810.220625